• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Radiol . Qualitative and quantitative chest CT parameters as predictors of specific mortality in COVID-19 patients

tetano

Editor, Senior Moderator
Emerg Radiol


. 2020 Oct 29;1-10.
doi: 10.1007/s10140-020-01867-1. Online ahead of print.
Qualitative and quantitative chest CT parameters as predictors of specific mortality in COVID-19 patients


Davide Colombi[SUP] 1 [/SUP], Gabriele D Villani[SUP] 2 [/SUP], Gabriele Maffi[SUP] 2 [/SUP], Camilla Risoli[SUP] 2 [/SUP], Flavio C Bodini[SUP] 2 [/SUP], Marcello Petrini[SUP] 2 [/SUP], Nicola Morelli[SUP] 2 [/SUP], Pietro Anselmi[SUP] 2 [/SUP], Gianluca Milanese[SUP] 3 [/SUP], Mario Silva[SUP] 3 [/SUP], Nicola Sverzellati[SUP] 3 [/SUP], Emanuele Michieletti[SUP] 2 [/SUP]



Affiliations
Free PMC article

Abstract

Purpose: To test the association between death and both qualitative and quantitative CT parameters obtained visually and by software in coronavirus disease (COVID-19) early outbreak.
Methods: The study analyzed retrospectively patients underwent chest CT at hospital admission for COVID-19 pneumonia suspicion, between February 21 and March 6, 2020. CT was performed in case of hypoxemia or moderate-to-severe dyspnea. CT scans were analyzed for quantitative and qualitative features obtained visually and by software. Cox proportional hazards regression analysis examined the association between variables and overall survival (OS). Three models were built for stratification of mortality risk: clinical, clinical/visual CT evaluation, and clinical/software-based CT assessment. AUC for each model was used to assess performance in predicting death.
Results: The study included 248 patients (70% males, median age 68 years). Death occurred in 78/248 (32%) patients. Visual pneumonia extent > 40% (HR 2.15, 95% CI 1.2-3.85, P = 0.01), %high attenuation area - 700 HU > 35% (HR 2.17, 95% CI 1.2-3.94, P = 0.01), exudative consolidations (HR 2.85-2.93, 95% CI 1.61-5.05/1.66-5.16, P < 0.001), visual CAC score > 1 (HR 2.76-3.32, 95% CI 1.4-5.45/1.71-6.46, P < 0.01/P < 0.001), and CT classified as COVID-19 and other disease (HR 1.92-2.03, 95% CI 1.01-3.67/1.06-3.9, P = 0.04/P = 0.03) were significantly associated with shorter OS. Models including CT parameters (AUC 0.911-0.913, 95% CI 0.873-0.95/0.875-0.952) were better predictors of death as compared to clinical model (AUC 0.869, 95% CI 0.816-0.922; P = 0.04 for both models).
Conclusions: In COVID-19 patients, qualitative and quantitative chest CT parameters obtained visually or by software are predictors of mortality. Predictive models including CT metrics were better predictors of death in comparison to clinical model.
 
Back
Top Bottom